Zenas Wins Dismissal Of IPO Suit Over R&D Spending Claims

By Katryna Perera · June 30, 2026, 8:00 PM EDT

A Massachusetts federal judge has permanently dismissed an investor suit alleging Zenas BioPharma hid how quickly it was spending money before its 2024 initial public offering, saying the company warned investors...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Buathongsri v. Zenas BioPharma, Inc. et al

Case Number

1:25-cv-10988

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

April 16, 2025